Alexandra Desnoyers

Greenfield Park, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

Differential Treatment Effects by Smoking Status for NSCLC Therapies (2010-2023): A Meta-Analysis.

Journal: JTO clinical and research reports
Published: November 21, 2024

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.

Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer.

Journal: Scientific reports
Published: July 10, 2023

Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021.

Meta-analysis of sex and racial subgroup participation rates and differential treatment effects for trials in solid tumor malignancies leading to US Food and Drug Administration registration between 2010 and 2021.

Journal: Cancer
Published: April 04, 2023

Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration.

Magnitude of effect and sample size justification in trials supporting anti-cancer drug approval by the US Food and Drug Administration.

Journal: Scientific reports
Published: March 28, 2023

Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion.

Management of Oligometastatic Breast Cancer: An Expert Committee's Opinion.

Journal: Current oncology (Toronto, Ont.)
Published: December 06, 2022

Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021.

Differential treatment effect between younger and older adults for new cancer therapies in solid tumors supporting US Food and Drug Administration approval between 2010 and 2021.

Journal: Cancer
Published: November 16, 2022

Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40-49.

Perceived guideline clarity impacts guideline-concordant care for breast cancer screening in women age 40-49.

Journal: BMC women's health
Published: October 20, 2022

Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40-49 years: a qualitative analysis.

Determinants of guideline-concordant breast cancer screening by family physicians for women aged 40-49 years: a qualitative analysis.

Journal: CMAJ open
Published: October 18, 2022

A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time.

A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time.

Journal: Scientific reports
Published: October 01, 2021

Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?

Adjuvant Zoledronate Therapy for Women With Breast Cancer-Effective Treatment or Fool's Gold?

Journal: JAMA oncology
Published: June 24, 2021

Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer.

Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer.

Journal: NPJ breast cancer
Published: May 05, 2021

Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis.

Platinum-based chemotherapy in early-stage triple negative breast cancer: A meta-analysis.

Journal: Cancer treatment reviews
Published: March 05, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026